Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24799664)

1.

CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia.

Pedersen SK, Mitchell SM, Graham LD, McEvoy A, Thomas ML, Baker RT, Ross JP, Xu ZZ, Ho T, LaPointe LC, Young GP, Molloy PL.

Epigenetics. 2014 Aug;9(8):1071-82. doi: 10.4161/epi.29046. Epub 2014 May 6.

2.

Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.

Mori Y, Olaru AV, Cheng Y, Agarwal R, Yang J, Luvsanjav D, Yu W, Selaru FM, Hutfless S, Lazarev M, Kwon JH, Brant SR, Marohn MR, Hutcheon DF, Duncan MD, Goel A, Meltzer SJ.

Endocr Relat Cancer. 2011 Jul 4;18(4):465-78. doi: 10.1530/ERC-11-0083. Print 2011 Aug.

3.

A panel of genes methylated with high frequency in colorectal cancer.

Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, Duesing KR, Buckley MJ, Dunne R, Beetson I, Rand KN, McEvoy A, Thomas ML, Baker RT, Wattchow DA, Young GP, Lockett TJ, Pedersen SK, Lapointe LC, Molloy PL.

BMC Cancer. 2014 Jan 31;14:54. doi: 10.1186/1471-2407-14-54.

4.

DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.

Ashktorab H, Daremipouran M, Goel A, Varma S, Leavitt R, Sun X, Brim H.

Epigenetics. 2014 Apr;9(4):503-12. doi: 10.4161/epi.27644. Epub 2014 Jan 17.

5.

The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.

Tóth K, Galamb O, Spisák S, Wichmann B, Sipos F, Valcz G, Leiszter K, Molnár B, Tulassay Z.

Pathol Oncol Res. 2011 Sep;17(3):503-9. doi: 10.1007/s12253-010-9338-7. Epub 2011 Jan 26.

PMID:
21267688
6.

Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.

Roperch JP, Incitti R, Forbin S, Bard F, Mansour H, Mesli F, Baumgaertner I, Brunetti F, Sobhani I.

BMC Cancer. 2013 Dec 1;13:566. doi: 10.1186/1471-2407-13-566.

7.

Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.

Takane K, Midorikawa Y, Yagi K, Sakai A, Aburatani H, Takayama T, Kaneda A.

Cancer Med. 2014 Oct;3(5):1235-45. doi: 10.1002/cam4.273. Epub 2014 May 24.

8.

[Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor].

Qi J, Zhu YQ, Luo J, Tao WH, Zhang JM.

Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):842-5. Chinese.

PMID:
18396643
9.

Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.

Ausch C, Kim YH, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich J, Grady WM.

Clin Chem. 2009 Aug;55(8):1559-63. doi: 10.1373/clinchem.2008.122937. Epub 2009 Jun 18.

10.

The roles of JK-1 (FAM134B) expressions in colorectal cancer.

Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK.

Exp Cell Res. 2014 Aug 1;326(1):166-73. doi: 10.1016/j.yexcr.2014.06.013. Epub 2014 Jun 25.

PMID:
24973512
11.
12.

Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.

Zhang H, Zhu YQ, Wu YQ, Zhang P, Qi J.

World J Gastroenterol. 2014 May 28;20(20):6329-35. doi: 10.3748/wjg.v20.i20.6329.

13.

Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression.

Ibrahim AE, Arends MJ, Silva AL, Wyllie AH, Greger L, Ito Y, Vowler SL, Huang TH, Tavaré S, Murrell A, Brenton JD.

Gut. 2011 Apr;60(4):499-508. doi: 10.1136/gut.2010.223602. Epub 2010 Nov 10.

PMID:
21068132
14.

Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.

Oliveira Frick V, Rubie C, Ghadjar P, Faust SK, Wagner M, Gräber S, Schilling MK.

Tumour Biol. 2011 Feb;32(1):189-96. doi: 10.1007/s13277-010-0112-y. Epub 2010 Sep 24.

PMID:
20865359
15.

Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.

Cao J, Chen XP, Li WL, Xia J, Du H, Tang WB, Wang H, Chen XW, Xiao HQ, Li YY.

World J Gastroenterol. 2007 Feb 21;13(7):1018-26.

16.

Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.

Celesti G, Di Caro G, Bianchi P, Grizzi F, Basso G, Marchesi F, Doni A, Marra G, Roncalli M, Mantovani A, Malesci A, Laghi L.

Gastroenterology. 2013 Sep;145(3):647-57.e15. doi: 10.1053/j.gastro.2013.05.011. Epub 2013 May 15.

PMID:
23684708
17.

Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.

Liu W, Guan M, Su B, Ye C, Li J, Zhang X, Liu C, Li M, Lin Y, Lu Y.

Cancer Biol Ther. 2010 Jun 1;9(11):862-71. Epub 2010 Jun 26.

PMID:
20364105
18.

Highly methylated genes in colorectal neoplasia: implications for screening.

Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, Oberg AL, Ahlquist DA.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2686-96.

19.

CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients.

Harder J, Engelstaedter V, Usadel H, Lassmann S, Werner M, Baier P, Otto F, Varbanova M, Schaeffner E, Olschewski M, Blum HE, Opitz OG.

Br J Cancer. 2009 Jan 27;100(2):360-5. doi: 10.1038/sj.bjc.6604859. Epub 2009 Jan 13.

20.

Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.

Tong JD, Jiao NL, Wang YX, Zhang YW, Han F.

Neoplasma. 2011;58(5):441-8.

PMID:
21744999
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk